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Optogenetics is a versatile combination of 
light-sensitive molecular tools and pho-
tonics, which has transformed neuroscience 
by enabling light-mediated manipulations 
of cellular physiology.[1] The scope of the 
technique continues to expand through 
molecular engineering of microbial opsin 
genes,[2] transgenic and viral technologies 
for expressing opsins in neural tissues,[3] 
and innovations in the delivery of light to 
opsin-expressing cells.[4] Most studies use 
lasers or solid-state light-emitting diodes 
plus relay optics for optogenetic photostim-
ulation, but the challenges presented by 
long-term in vivo studies and optogenetics-
based visual and auditory neural prostheses 
are creating demand for novel photonic 
components.[5] Here, the feasibility of 
organic light-emitting diodes (OLEDs) as 
a lens-free method for photostimulation 
in optogenetics is demonstrated in vitro, 
laying a foundation for their incorporation 
in bioimplantable devices.
OLEDs are a distinct class of optical 
element contrasting with other light 
sources in design, because their emis-
sion emanates from a planar surface com-
prising a thin layer of an organic electroluminescent material 
sandwiched between two electrodes. Conceptually, this enables 
lens-free lab-on-chip designs since their thin structure allows 
OLEDs to be interfaced closely with biological samples without 
external relay optics. The emissive area of an OLED can have 
a wide range of physical scales, from millimeters or even cen-
timeters (e.g., for sample illumination) to a few micro meters (to 
provide single-cell specificity and finely structured illumination).
OLEDs can be deposited on diverse substrates, including, 
importantly, active matrix backplanes (e.g., complementary 
metal oxide semiconductors (CMOS) or thin-film transistor 
arrays), to electrically address many pixels.[6] OLEDs can also 
be fabricated on lightweight flexible thin plastic films, offering 
opportunities for minimally invasive biocompatible implants.[7] 
Through engineering of the device electrodes, it is possible 
to design optically transparent OLEDs, which in the future 
may allow transillumination for imaging and microscopy. By 
selecting appropriate electroluminescent molecules, OLEDs 
can address the entire visible spectrum. Emissive layers of dif-
ferent colors can be stacked or spatially multiplexed to widen 
coverage of the spectrum from a single device.
Optogenetics, photostimulation of neural tissues rendered sensitive to 
light, is widely used in neuroscience to modulate the electrical excitability 
of neurons. For effective optical excitation of neurons, light wavelength and 
power density must fit with the expression levels and biophysical properties 
of the genetically encoded light-sensitive ion channels used to confer light 
sensitivity on cells—most commonly, channelrhodopsins (ChRs). As light 
sources, organic light-emitting diodes (OLEDs) offer attractive properties 
for miniaturized implantable devices for in vivo optical stimulation, but they 
do not yet operate routinely at the optical powers required for optogenetics. 
Here, OLEDs with doped charge transport layers are demonstrated that 
deliver blue light with good stability over millions of pulses, at powers 
sufficient to activate the ChR, CheRiff when expressed in cultured primary 
neurons, allowing live cell imaging of neural activity with the red genetically 
encoded calcium indicator, jRCaMP1a. Intracellular calcium responses scale 
with the radiant flux of OLED emission, when varied through changes in the 
current density, number of pulses, frequency, and pulse width delivered to the 
devices. The reported optimization and characterization of high-power OLEDs 
are foundational for the development of miniaturized OLEDs with thin-layer 
encapsulation on bioimplantable devices to allow single-cell activation in 
vivo.
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To date, work toward use of OLEDs for optogenetics has 
predominantly focused on light-sensitive biological model 
systems requiring low irradiances (power densities of the order 
of µW mm−2 or lower) to trigger their biological outputs. Blue-
emitting OLED microdisplays with pixels of the size of biolog-
ical cells and coated with thin-layer encapsulation (thickness, 
<1 µm) to protect the OLED from the aqueous environment 
were used to drive phototactic behavior in Chlamydomonas rein-
hardtii[8] and to elicit single-cell activation of measurable pho-
tocurrents in human embryonic kidney cell lines expressing 
channelrhodopsins (ChRs) cultured directly on the devices.[9] In 
visual neuroscience, OLED microdisplays have been adopted to 
output visual stimuli onto isolated retinae while making elec-
trophysiological recordings, allowing detailed characterizations 
of visual receptive fields and functional connectivity between 
neurons of the retina.[10] Toward applications with higher irra-
diance requirements, millimeter-scale high-brightness OLEDs 
(operating in the range of 0.25–0.4 mW mm−2) were used to 
elicit ChR-triggered muscular contractions in vivo in Drosophila 
larvae.[11]
In the present study, the effectiveness of further-improved 
high-power millimeter-scale blue pin-OLEDs is evaluated in an 
all-optical system for stimulating and reading out neural activity 
in cultured neurons. We used blue-emitting pin-OLEDs with a 
bottom-emitting configuration (i.e., emitting through the glass 
substrate; Figure 1a; see the Experimental Section for details 
on OLED design and fabrication). Imaging chambers with pri-
mary cultures of mouse hippocampal neurons were placed on 
top of the OLED substrate and imaged with an upright micro-
scope using a 40×/0.80 NA water-dipping objective (Figure 1b). 
The active area of the OLEDs was 16.36 mm2 and illuminated 
the entire field of view. Like in earlier work on ChR-triggered 
muscular contractions in Drosophila larvae,[11] we used the 
fluorescent emitter material 2,5,8,11-tetra-tert-butylperylene 
(TBPe) to achieve good overlap of the OLED emission spectrum 
(λmax = 463 nm) with the reported activation spectrum for 
CheRiff (λmax ≈ 460 nm),[12] a ChR with enhanced blue light 
sensitivity (Figure 1c). OLED electroluminescence and cur-
rent density measurements (Figure 1d) indicated that a target 
optical power density of ≈0.2 mW mm−2, previously reported 
to reliably trigger action potential firing in neurons expressing 
CheRiff,[12] was reached at modest driving voltages around 5 V 
(Figure 1d). Thus, OLED-mediated photostimulation of CheRiff 
expressed in cultured neurons was expected to generate meas-
urable cellular responses. We also tested the stability of our 
OLEDs under high-brightness pulsed operation (optical power 
density, 0.5 mW mm−2; pulse duration, 10 ms) and found that 
even after generating 1 million excitation pulses, the power 
density provided by our devices degraded by only about 20% 
indicating that these OLEDs likely have sufficient stability for 
extended in vivo experiments (Figure 1e).
Two recombinant adeno-associated virus (rAAV) vectors, one 
encoding CheRiff (tagged with eGFP) and the other encoding 
jRCaMP1a, a red genetically encoded calcium indicator (GECI), 
were used to transduce primary cultures of mouse hippocampal 
neurons. Robust expression, driven by a synapsin promoter, of 
both CheRiff-eGFP and jRCaMP1a was observed in most neu-
rons from 1-week post-transduction onward. Confocal micros-
copy revealed that, qualitatively, expression patterns of both 
vectors agreed well with their original descriptions,[12,13] with 
CheRiff-eGFP being highly membrane localized and jRCaMP1a 
being cytosolic and well exported from the nucleus (Figure 2a). 
Robust signal over background and a strong linear correlation 
between intensities of the two constructs were observed in neu-
ronal cell bodies (Figure 2b,c). Signal intensities through the 
z-plane at neuronal cell bodies indicated that maximal CheRiff 
signal straddled cytosolic expression of jRCaMP1a outside the 
nucleus (Figure 2d). Collectively, these data verified that viral 
transduction with two rAAV vectors resulted in both CheRiff 
and jRCaMP1a being extensively coexpressed in our system 
and that they localized appropriately within neurons for optical 
stimulation and readout of neural activity.
Next, we interfaced the CheRiff- and jRCaMP1a-expressing 
neurons with OLEDs on a calcium imaging microscope setup 
and measured the neuronal responses to pulsed blue illumi-
nation from OLEDs (Figure 1b). We started by monitoring 
jRCaMP1a responses in neurons to a fixed train of 100 optical 
pulses from the OLED, with a duration of 10 ms each at 
80 Hz (Figure 3a,b; Video S1, Supporting Information). Cur-
rent densities between 6 and 1125 mA cm−2 were applied 
to the OLED, corresponding to optical power densities out-
putted by the OLED ranging from just under 10 µW mm−2 to 
≈0.8 mW mm−2. Prior to optical stimulation, jRCaMP1a gener-
ated a clearly detectable and flat baseline of red fluorescence, 
indicating that the incident excitation light used for jRCaMP1a 
imaging did not cause significant CheRiff activation. During 
optical stimulation, the readout from cells was obscured by 
the emission of the OLED light bleeding through the 600 nm 
long-pass filter used for jRCaMP1a imaging. Immediately post-
stimulation, significant increases in intracellular jRCaMP1a 
signal were recorded for all but the lowest optical power density 
tested and decayed with a half-decay time on the order of 3 s, 
consistent with the reported kinetics for jRCaMP1a in response 
to hundreds of action potentials.[13] At current densities below 
20 mA cm−2 (corresponding to optical power densities inci-
dent on cells of less than 10 µW mm−2), no neuronal responses 
were distinguishable above baseline noise levels (Figure 3b,c). 
At 62.5 mA cm−2 (≈60 µW mm−2 optical power density), peak 
signal/baseline jRCaMP1a responses immediately poststimu-
lation reached 0.08 and approached a signal-to-noise (SNR) 
ratio of 3× the standard deviation (SD) of the baseline signal 
during the 2 s prior to stimulation (Figure 3d). Peak jRCaMP1a 
responses rapidly increased with increasing current densities, 
reaching signal/baseline of 0.5 and an SNR >20× SD of baseline 
at 750 mA cm−2 (≈0.5 mW mm−2). For even higher current den-
sities, there was some tailing off in peak response amplitude, 
likely due to diminishing neuronal spike fidelity in response 
to photostimulation of CheRiff at higher frequencies.[12] 
Photostimulation-induced changes in jRCaMP1a signal were 
the result of CheRiff activation, since no detectable increases in 
jRCaMP1a signal were detected in matched neuronal cultures 
transduced with jRCaMP1a but not CheRiff (Figure 3b).
Next, we explored the minimum number of OLED light 
pulses that would elicit neuronal responses to photostimulation 
(again using 10 ms duration pulses at 80 Hz repetition rate and 
now using a fixed power density of 0.8 mW mm−2; Figure 4a). 
As expected, the amplitude of recorded neuronal jRCaMP1a 
responses increased as pulse trains of OLED photostimulation 
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Figure 1. Properties of pin-OLEDs for in vitro optogenetics. a) OLED stack diagram, presented in the orientation in which devices were used in 
experiments (see the Experimental Section for details). b) Illustration of the optical setup used, incorporating bottom-emitting pin-OLED for optogenetic 
photostimulation and 40×/0.80 NA water-dipping objective on an upright epifluorescence microscope configured for red GECI imaging. Image 
acquisition was triggered and OLED emission controlled by a source measure unit. c) Combined plot showing the measured OLED emission spectrum 
(blue squares), the activation spectrum of CheRiff[12] (black circles), and the excitation (ex.; green upward triangles) and emission (em.; red downward 
triangles) spectra of jRCaMP1a in the Ca2+-bound state.[13] Also shown are the excitation (green band) and emission (red band) wavelengths used for 
imaging jRCaMP1a responses. d) Current densities (black squares, left y-axis) and optical power densities (blue circles, right y-axis) measured for the 
16.36 mm2 OLED pixel. e) OLED stability under pulsed operation, applying 1 million constant-current pulses of 611 mA cm−2 and 10 ms duration, with 
10 Hz repetition rate. Optical power density (black line, left y-axis) generated during current pulses and corresponding bias voltage (red line, right y-axis).
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were lengthened to include more pulses. Ten pulses or more 
were required to generate jRCaMP1a responses statistically dis-
tinguishable from baseline noise levels, i.e., having an SNR of 
>3× above the SD of the baseline signal; even a single excitation 
pulse produces an SNR slightly larger than 1 SD above baseline 
(Figure 4b,c).
To characterize calcium responses at less saturating stimu-
lation frequencies and capture data between OLED pulses, 
we varied the duty cycle of OLED photostimulation. Figure 5a 
shows responses to 100 pulses, each 10 ms in duration, deliv-
ered at frequencies from 1 to 20 Hz (equating to duty cycles 
of 1–20%). Images acquired between OLED pulses delivered 
in this frequency range provided a readout of calcium sum-
mation during the period of OLED photostimulation. As was 
observed after stimulation with an individual pulse (Figure 4a), 
neuronal responses to each pulse within a 1 Hz pulse train 
were only marginally resolvable above the noise levels of the 
preceding prestimulus period. However, with successive 
pulses, the jRCaMP1a signal rapidly summated before reaching 
a steady-state signal/baseline of 0.15 after around 20 pulses. At 
higher photostimulation repetition rates of 5, 10, and 20 Hz, 
intracellular calcium continued to summate throughout the 
investigated stimulation period (Figure 5a).
Finally, at a fixed current (1125 mA cm−2) and frequency 
(40 Hz) of stimulation, we varied the width of individual pulses 
within the pulse train between 1 and 20 ms. Photostimulation 
with pulses of 1 and 3 ms substantially reduced the amplitude 
of jRCaMP1a signals measured immediately poststimulation 
(Figure 5b). Responses to 1 ms pulses were not distinguish-
able from noise levels but 3 ms pulses yielded signals above 
the threshold of detection in our system. The diminished 
responses to these shortened pulse widths are explained by 
the pulses being faster than the reported on-time of CheRiff 
(4.5 ms), i.e., the time over which CheRiff passes maximum 
photocurrents in hippocampal neurons.[12] Increasing the 
overall radiant flux by extending the pulse width to 20 ms 
(resulting in a duty cycle of 80%) resulted in jRCaMP1a 
responses with comparable amplitudes to stimulation at 80 Hz 
with 10 ms pulses.
Overall, these data show that it is feasible to use OLEDs for 
photostimulation in optogenetics and that their output is cus-
tomizable to the fundamental biophysical properties of spe-
cific ChRs. Although well matched to the CheRiff activation 
spectrum, a potential limitation of our study is that the OLED 
emission overlaps with the jRCaMP1a fluorescence emission. 
Even though the overlap is small (OLEDs show <1% relative 
emission at wavelengths >600 nm; Figure 1a), this precluded 
measurements of cellular jRCaMP1a signals during optical 
stimulation. Nonetheless, time-gated imaging permitted the 
recording of poststimulus neuronal calcium responses with 
ample temporal resolution for neuronal calcium dynamics 
and the dissociation kinetics of GECIs. Simultaneous OLED 
Adv. Biosys. 2019, 1800290
Figure 2. Coexpression of CheRiff and jRCaMP1a in cultured neurons transduced with rAAV vectors. a) Example fluorescence images of transduced 
neurons, from maximal projections of confocal z-stacks, pseudocolored with a green lookup table for CheRiff-eGFP and magenta for jRCaMP1a and 
shown as an overlay. Scale bars: 20 µm. b) Linear fit to integrated intensities of jRCaMP1a against CheRiff-eGFP intensity at cell bodies (n = 39 cells; 
Pearson correlation coefficient: 0.84). c) Distributions of integrated signal intensities for CheRiff-eGFP and jRCaMP1a in neuronal cell bodies as 
measured in part (b). Line indicates average. d) Average z-profiles from ROIs placed over the presumed nuclei in jRCaMP1a z-stacks of neurons 
(n = 10 cells) to quantify the localization of CheRiff-eGFP and jRCaMP1a.
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stimulation and readout of neural excitation at temporal resolu-
tions much higher than the imaging rate of 50 s−1 used here 
could deploy genetically encoded voltage indicator imaging, 
which typically operates at longer wavelengths,[12,14] or could 
record neuronal excitation using electrophysiology. Alter-
natively, the emission of OLEDs could be rendered more 
narrowband through introduction of a microcavity designed to 
selectively outcouple light at the desired wavelength.
Our work provides the basis for the future use of pin-OLEDs 
for lens-free in vivo photostimulation of neurons expressing 
ChRs, possibly with single-cell specificity. Due to the use 
of doped charge transport layers, the pin-OLEDs used here 
reach sufficient optical power density for photostimulation of 
ChR-expressing neurons at drive voltages below 5 V. This will 
simplify integration of OLEDs for photostimulation of neurons 
on CMOS technology–based driver chips, which are often lim-
ited in their maximum available output voltage, but allow defi-
nition of OLED pixels with cell-scale dimensions, i.e., less than 
10 µm × 10 µm. The low driving voltage also reduces ohmic 
losses in the OLED, thus minimizing potentially adverse device 
heating. Continued refinements in molecular engineering now 
enable restricted expression of ChRs to neuronal cell bodies, 
a critical step in avoiding aberrant activation of distant cells 
via activation of en-passant ChR-expressing axons and den-
drites.[15] In combination, these developments open the future 
possibility of a microscopic version of the high-brightness 
OLEDs used here to enable lens-free yet single-cell-specific 
photostimulation.
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Figure 3. Responses of CheRiff-expressing neurons to OLED photostimulation at different current densities applied to the OLED. a) Individual frames 
from a representative jRCaMP1a calcium imaging time series before stimulation (0 s), immediately following OLED photostimulation (3.25 s), and 30 s 
after OLED photostimulation (30 s). Stimulation parameters: 100 pulses, each 10 ms in duration, delivered at 80 Hz, current density of 1125 mA cm−2 
applied to OLED outputting an optical power density of ≈0.8 mW mm−2. b) Mean jRCaMP1a responses (signal/baseline) of n = 10 neurons to 
stimulation by OLED pulse train (blue bar) at different device current densities (indicated). Signal during OLED stimulation is omitted for clarity. 
c) jRCaMP1a signal/baseline as a function of current density at the OLED pixel (filled circles = mean, error bar = standard deviation, n = 10 cells). 
Also shown (square symbol, no CheRiff) are measurements from cells transduced with jRCaMP1a but not CheRiff (current density 1125 mA cm−2, 
symbol = mean, error bar = standard deviation, n = 10 cells). d) jRCaMP1a signal-to-noise ratio as a function of current density of the OLED pixel 
(symbol = mean, error bar = standard deviation, n = 10 cells).
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Figure 5. Neuronal calcium responses to varying duty cycles of OLED photostimulation. a) jRCaMP1a signal/baseline traces (purple lines: mean 
response from n = 10 cells) in response to OLED photostimulation (blue bars) at different repetition rates. Stimulation parameters: 100 pulses, 10 ms 
duration, OLED pixel current density 1125 mA cm−2, optical power density 0.8 mW mm−2, delivered at the indicated repetition rates. b) Mean jRCaMP1a 
signal/baseline traces (purple lines, n = 10 cells) in response to OLED photostimulation with trains containing pulses of different widths. Stimulation 
parameters: 100 pulses, repetition rate 40 Hz, current density at OLED pixel 1125 mA cm−2, optical power density 0.8 mW mm−2, pulse width as indicated.
Figure 4. Sensitivity threshold of neuronal responses to varying numbers of OLED pulses. a) Signal/baseline jRCaMP1a mean traces (n = 10 cells) 
for the indicated number of pulses of OLED photostimulation (stimulation parameters: 10 ms duration pulses, delivered at 80 Hz, current density 
of 1125 mA cm−2 outputting roughly 0.8 mW mm−2). b) jRCaMP1a signal/baseline as a function of the number of pulses of OLED photostimulation 
(symbol = mean, error bar = standard deviation, n = 10 cells). c) jRCaMP1a SNR as a function of the number of pulses of OLED photostimulation 
(symbol = mean, error bar = standard deviation, n = 10 cells).
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Experimental Section
OLED Fabrication and Characterization: OLEDs were fabricated in a 
high-vacuum chamber (Angstrom Engineering) at a base pressure of 
10−7 mbar. All materials were purchased from commercial suppliers. 
Organic materials were evaporated sequentially onto glass substrates 
coated with a prestructured indium tin oxide (ITO) anode. ITO 
anode length connecting to the OLED pixel was reduced from 4 mm 
in initial devices (Figure 1e) to less than 1 mm for devices used in 
optogenetic experiments (Figure 1d). Layer thickness was monitored in 
situ using quartz crystal monitors. Devices were composed of the 
following layers of materials: hole transport layer, thickness: 40 nm, 
2,2′,7,7′-tetrakis(N,N′-di-p-methylphenylamino)-9,9′-spirobifluorene 
p-doped with 2,2′-(perfluoronaphthalene-2,6-diylidene)dimalononitrile 
(4 wt%); electron blocking layer, thickness: 10 nm, 2,2′,7,7′-tetrakis(N,N-
diphenylamino)-9,9-spirobifluorene; emission layer, thickness: 20 nm, 
TBPe doped at 1.5 wt% into the host 2-methyl-9,10-bis(naphthalen-
2-yl)anthracene; hole blocking layer, thickness: 10 nm, bis(2-methyl-8-
quinolinolate)-(4-phenylphenolato)aluminum(III); electron transport 
layer, thickness: 40 nm, cesium-doped 4,7-diphenyl-1,10-phenanthroline 
(3 wt%); cathode, thickness: 100 nm, aluminum. OLEDs were fabricated 
in one run using shadow masks and subsequently encapsulated under 
nitrogen atmosphere using glass lids and epoxy resin. Each substrate 
contained four identical OLEDs with an active area of 16.36 mm2.
Primary Culture and Viral Transduction of Neurons: All animal care 
and procedures were in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986 and animals culled by Schedule 1 
methods. Hippocampi from unsexed postnatal day 2–3 C57BL/6 
laboratory mouse pups were dissected and pooled in ice-cold DPBS. 
Tissue was treated with papain (10 units mL−1) for 22 min at 37 °C 
and then disaggregated by repeated pipetting in Dulbecco’s modified 
Eagle medium/nutrient mixture F-12 containing 10% fetal bovine 
serum. Cells were pelleted by centrifugation for 5 min at 200 ×  g and 
resuspended in culture medium (Neurobasal-A supplemented with 
B-27 and 0.5 × 10−3 m GlutaMax-I). Cells were then seeded at a nominal 
initial density of 400 cells mm−2 on polyornithine and laminin-coated 
10 mm diameter glass coverslips housed in 24-well plates maintained 
in a humidified incubator at 37 °C and 5% CO2. At 4–7 d in vitro, 
cultures were transduced with independent rAAV particle preparations 
packaging CheRiff[12] and jRCaMP1a[13] (2 × 109 gc per coverslip) while 
performing a 50% volume change of culture medium. DRH337:AAV-
hsyn-CheRiff-eGFP was a gift from Adam Cohen (Addgene plasmid # 
51697). AAV1/2 particles of hsyn-CheRiff-eGFP were produced in HEK 
cells and concentrated by heparin column purification.[16] AAV1 virions 
for jRCaMP1a (AAV1.Syn.NES.jRCaMP1a.WPRE.SV40) were prepared by 
the University of Pennsylvania Vector Core.
OLED and Live Cell Imaging Setup: OLEDs were mounted in a custom 
sample holder on the stage of an upright microscope and connected 
electrically to a source measure unit (SMU Keithley 2450). Incident 
light for imaging jRCaMP1a was from a fiber-coupled mercury arc lamp 
attenuated with neutral-density filters and filtered 560/20 nm. Emission 
was collected above 600 nm on an sCMOS camera (Andor Neo) at 50 s−1 
with 8 × 8 pixel binning through a 40×/0.80 NA water-dipping objective. 
Electrical control of OLEDs was performed using Python scripts to 
program the SMU: a trigger pulse was sent from the SMU to initiate 
acquisition from the camera for 2 s and then deliver constant-current 
pulse trains to the OLEDs with varied currents, pulse widths, numbers 
of pulses, and pulse frequency, as described in the text. Experiments 
were performed at room temperature (20–22 °C). The bath solution for 
imaging was 125 × 10−3 m NaCl, 2.5 × 10−3 m KCl, 3 × 10−3 m CaCl2, 
1 × 10−3 m MgCl2, 10 × 10−3 m HEPES, and 30 × 10−3 m glucose, pH 7.3. 
Experiments were performed under pharmacological blockade of AMPA, 
kainate, and NMDA receptors with 10 × 10−6 m CNQX and 25 × 10−6 m 
d-APV, since optical stimulation triggered recurrent network activity in 
untreated cultures.
Image Analysis: Raw image sequences from calcium imaging were 
exported to a FIJI ImageJ distribution for analysis.[17] Identically sized 
regions of interest (ROIs) were placed over manually identified neuronal 
cell bodies using the Time Series Analyzer plug-in. Mean pixel intensity 
within each of these ROIs was then calculated for each frame. To normalize 
traces for variation in basal fluorescence levels, traces are presented as 
signal/baseline, where signal is the difference between fluorescence at any 
given time point and the average fluorescence within the 100 frames (2 s) 
acquired before the OLED stimulus (baseline). The signal/baseline data 
are thus comparable to a ΔF/F0 value, except that the baseline averaging 
reduces noise vs using only a single initial point in time as is sometimes 
implied by the term F0. Where individual signal/baseline values are 
presented, these are the average signal from the five frames immediately 
post-OLED stimulation. Where signal-to-noise ratio is presented, signal is 
defined as above, with noise being calculated as the standard deviation of 
pixel intensity values during the 100 frames (2 s) before stimulation.
Data Availability: The research data supporting this publication can 
be accessed at https://doi.org/10.17630/ 80cbac70- 227e-4564- 9a8c- 
 937257e9c49d.
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